Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) Invested Capital (2020 - 2025)

Bio Essence (BIOE) has 6 years of Invested Capital data on record, last reported at -$3.1 million in Q3 2025.

  • For Q3 2025, Invested Capital fell 5.45% year-over-year to -$3.1 million; the TTM value through Sep 2025 reached -$3.1 million, down 5.45%, while the annual FY2024 figure was -$3.0 million, 79.95% down from the prior year.
  • Invested Capital reached -$3.1 million in Q3 2025 per BIOE's latest filing, roughly flat from -$3.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $883.7 million in Q3 2021 and bottomed at -$3.4 million in Q1 2023.
  • Average Invested Capital over 5 years is $44.3 million, with a median of -$2.7 million recorded in 2022.
  • Peak YoY movement for Invested Capital: surged 52337.3% in 2021, then plummeted 1892.09% in 2022.
  • A 5-year view of Invested Capital shows it stood at -$2.4 million in 2021, then plummeted by 33.62% to -$3.2 million in 2022, then surged by 48.91% to -$1.6 million in 2023, then crashed by 79.95% to -$3.0 million in 2024, then decreased by 4.48% to -$3.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were -$3.1 million in Q3 2025, -$3.1 million in Q2 2025, and -$3.2 million in Q1 2025.